Literature DB >> 7002182

Measurement of serum drug levels in the assessment of antidepressants.

S A Montgomery.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 7002182      PMCID： PMC1430140          DOI： 10.1111/j.1365-2125.1980.tb01781.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  36 in total

1.  Plasma nortriptyline and clinical response.

Authors:  G Burrows; B A Scoggins; L R Turecek; B Davies
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

2.  Plasma concentration of amitriptyline and clinical response.

Authors:  R A Braithwaite; R Goulding; G Theano; J Bailey; A Coppen
Journal:  Lancet       Date:  1972-06-17       Impact factor: 79.321

3.  Plasma-nortriptyline levels in endogenous depression.

Authors:  P Kragh-Sørensen; M Asberg; C Eggert-Hansen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

4.  Plasma concentration of nortriptyline and clinical response in depressive illness.

Authors:  G D Burrows; B Davies; B A Scoggins
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

5.  Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. II.

Authors:  C Gurney; M Roth; R F Garside; T A Kerr; K Schapira
Journal:  Br J Psychiatry       Date:  1972-08       Impact factor: 9.319

6.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

7.  Depression, Delusions, and Drug Response.

Authors:  A H Glassman; S J Kantor; M Shostak
Journal:  Am J Psychiatry       Date:  1975-07       Impact factor: 18.112

8.  Diagnostic criteria for use in psychiatric research.

Authors:  J P Feighner; E Robins; S B Guze; R A Woodruff; G Winokur; R Munoz
Journal:  Arch Gen Psychiatry       Date:  1972-01

9.  Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levels: a randomized double-blind study controlled by plasma concentrations in patients with endogenous depression.

Authors:  P Kragh-Sorensen; C E Hansen; P C Baastrup; E F Hvidberg
Journal:  Psychopharmacologia       Date:  1976-02-02

10.  Relationship between plasma level and therapeutic effect of nortriptyline.

Authors:  M Asberg; B Crönholm; F Sjöqvist; D Tuck
Journal:  Br Med J       Date:  1971-08-07
View more
  6 in total

1.  Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.

Authors:  S A Montgomery; D Roy; S Wynne-Willson; C Robinson; D B Montgomery
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  Strategies for the drug treatment of depression.

Authors:  A J Cooper; R V Magnus
Journal:  Can Med Assoc J       Date:  1984-02-15       Impact factor: 8.262

3.  The clinical assessment of depression.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of clomipramine.

Authors:  A E Balant-Gorgia; M Gex-Fabry; L P Balant
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

5.  Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels.

Authors:  U Breyer-Pfaff; H J Gaertner; F Kreuter; G Scharek; M Brinkschulte; R Wiatr
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Antidepressive effect of amitriptyline treatment with plasma drug levels controlled within three different ranges.

Authors:  J E Burch; O Ahmed; R P Hullin; R H Mindham
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.